$3.57 0.02 (+0.56%)
11/20/2009 4:01 PM

K V Pharmaceutical Company (KV-A)

CAPS Rating: 5 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Current Price $3.57 Mkt Cap $178.31M
Open $3.51 P/E Ratio 1.90
Prev. Close $3.55 Div. (Yield) N/A (N/A)
Daily Range $3.50 - $3.60 Volume 217,528
52-Wk Range $0.40 - $6.51 Avg. Daily Vol. 577,000

KV-A News and Commentary

Caps

How do you think KV-A will perform vs the S&P 500?

Add Stock to Watchlist

All Members

308 Outperform
10 Underperform
 

All-Star Members

121 Outperform
2 Underperform
 

Wall Street

0 Outperform
1 Underperform
 

Top KV-A Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

AllStarPortfolio (64.82)
Submitted September 22, 2009

On September 21, 2009 at 11:14 PM, ChrisGraley (99.23) wrote:

Solaris asked to put forth a better pitch for this stock so here goes...

KV.A has currently has 3 major brands that they sell.

The Ther-RX brand is… More

KurtNYC (67.33)
Submitted July 27, 2009

KV’s auditor, KPMG, plans to raise substantial doubt about KV’s ability to continue as a going concern, as KV struggles with its liquidity andfinancial losses.
July 24, 2009

KV-A VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about KV-A.

Recs

0
Member Avatar AndrewGreenBull (98.06) Submitted: 11/16/2009 10:41:21 AM : Outperform Start Price: $3.67 KV-A Score: -2.81

Infrastructure problem will be fixed

Recs

0
Member Avatar lincolnsixecho (< 20) Submitted: 11/13/2009 7:45:55 AM : Outperform Start Price: $3.23 KV-A Score: +10.42

This company has been around for a while, and survived some challenging markets. The issues with the FDA will turn out to be a cloud with a silver lining. Any corporation or organisation that survives the rigours of an FDA intervention, is a stable and attractive stock pick. KV.A is already showing signs of revitalisation.

Recs

0
Member Avatar airenInDebt (50.54) Submitted: 11/12/2009 2:05:02 PM : Underperform Start Price: $3.23 KV-A Score: -10.42

I don't think that this stock may have a little run based on artificial media hype, but don't believe the company has really that much to offer to create solid stock gains. So they are developing products to save money in manufacturing supplements and drugs and are also marketing generics. Big deal. There's safer and better places to put my money.

Leaderboard

Find the members with the highest scoring picks in KV-A.

Score Leader

Richpicks

Richpicks (47.32) Score: +81.55

The Score Leader is the member with the highest score across all their picks in KV-A.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
Richpicks 47.32 10/2/2008 Underperform 3W $22.27 -83.97% -2.42% +81.55
pdt24 < 20 11/14/2008 11/13/2009 Underperform 1Y $6.17 -42.14% +25.55% +67.69
lordpessimism 98.66 11/28/2007 Underperform 3M $28.16 -87.32% -21.50% +65.82
TerjeJames 37.72 12/13/2007 Underperform 3M $28.14 -87.31% -22.70% +64.61
HillBobby < 20 9/2/2009 Outperform 3W $2.20 +62.27% +10.19% +52.08 1 Comment
REDSONOITA 94.21 9/2/2009 Outperform 1Y $2.20 +62.27% +10.19% +52.08
katie321 71.82 9/2/2009 Outperform 3M $2.20 +62.27% +10.19% +52.08
cheev 94.91 7/27/2009 Outperform 5Y $2.18 +63.72% +12.43% +51.29
BicaChica 79.58 7/27/2009 Outperform 5Y $2.19 +63.01% +12.13% +50.88
Zookii 52.54 7/27/2009 Outperform 5Y $2.23 +60.09% +12.29% +47.80

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackMatrix 87.46 8/22/2006 Underperform NS $21.72 -83.56% -10.26% +73.31

Featured Broker Partners